Purchase Order 75N95023P00628
- Not listed
- Arizona State University (ASU) was awarded a $64,020 firm fixed-price purchase order by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, to conduct high-throughput immunoproteomics research on autoantibody profiles in aging populations. Under this contract, ASU will construct and perform antibody array testing targeting approximately 1,700 proteins and selected autoantigens across 270 blood samples from the Baltimore Longitudinal Study of Aging (BLSA)...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency within the U.S. Department of Health and Human Services, to Arizona State University (ASU) for $15,216.00. The contract has a period of performance ending on July 15, 2020 and does not have any set-aside designations. As a comprehensive public research university, ASU conducts a range of scientific research and development activities funded by federal...
- Arizona State University, doing business as Orspa, was awarded a firm fixed-price purchase order valued at approximately $971,000 by the National Institutes of Health National Institute on Aging to provide autoantibody immunoproteomics and aging services. Under the contract, Orspa will construct protein microarrays for 1,700 proteins and analyze 16,000 blood samples over 48 months to identify autoantibodies and investigate associations with autoimmune diseases and age-related conditions. There...
- Arizona State University (ASU) has been awarded a $297,824 research grant with a completion date of December 31, 2027, to execute a balanced science program aligned with guidance from the National Academies of Sciences, Engineering, and Medicine, administration priorities, and congressional direction. The award, issued January 1, 2026, by a civilian federal agency's Shared Services Center, supports research activities to be performed in Scottsdale, Arizona. This grant reflects ASU's...
- Arizona State University (ASU), operating through its Office of Research and Sponsored Projects Administration (Orspa), received a $439,622 research grant from a civilian federal agency's Shared Services Center, with a performance location in Tempe, Arizona. The award, issued on September 1, 2025, supports execution of a balanced science program aligned with discipline-specific guidance from the National Academies of Sciences, Engineering, and Medicine, administration priorities, and...
- This is a prime contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Arizona, doing business as the Arizona Board of Regents. The $13,812,898.37 contract is for biomedical research services and is not designated as a set-aside award. The University of Arizona is providing a range of specialized research capabilities to NIAID, including expertise in areas such as astrophysics, biomedical...
- This $249,132.00 firm-fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Northern Arizona University, a public research university located in Flagstaff, Arizona. The purpose of the contract is to provide the National Institute of Neurological Disorder and Stroke (NINDS) with a scientific research preparatory summer course. The contract does not have a set-aside designation and is scheduled...
- This is a $748,646.36 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Arizona State University (ASU) for the FY 21 Broad Agency Announcement (BAA) TOPIC 8 - ASU. The contract is a cost-no-fee arrangement and has an ultimate completion date of August 31, 2023. ASU, a large public research university, is the prime contractor and has not used any set-aside designations. The contract award indicates that ASU has an extensive history of receiving prime and...
- Arizona State University (ASU) was awarded a $150,000 research grant by a civilian federal agency's Shared Services Center with a completion date of November 18, 2028. This grant supports the execution of a balanced science program developed in accordance with discipline-specific guidance from the National Academies of Sciences, Engineering, and Medicine, administration priorities, and congressional direction. The work will be performed in Scottsdale, Arizona, and represents ASU's continued role...
- This is a federal contract award from the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to the University of Arizona, a public research university and land grant institution, for a clinical study on the effects of combined aspirin and zileuton treatment on tobacco-related carcinogenesis biomarkers in current smokers. The $1,476,557 award falls under the Cancer Prevention Agent Development Program 2012-2017 indefinite delivery vehicle, and has...
This federal contract award is a two-year no-cost extension to a longitudinal study on sex differences in autoantibodies and autoimmune diseases with aging, awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Arizona State University (ASU). The modified period of performance is now September 8, 2023 through September 7, 2027, with a ceiling value of $205,000.00. The contract is a firm fixed-price purchase order, and there was no set-aside used. ASU is a Hispanic-serving, state-controlled educational institution known for its extensive federal research and development capabilities, including work with agencies like NASA, the Department of Defense, and the National Institutes of Health. This award extension supports ASU's continued efforts in the longitudinal study of autoimmune conditions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | $0 | 9/9/25 | |
| Not listed | Not listed | $205.0k | 9/7/23 |